PBIGF Insider Trading 2026

Paradigm Biopharmaceuticals Limited - Executive & director stock transactions

Net Sentiment

Neutral

Insider Buys

Insider Sells

Stock Price

$0.18

No recent insider trading activity for PBIGF.

Get Full PBIGF Analysis

Institutional ownership, financials, and AI insights

View Full Analysis

Frequently Asked Questions

Are insiders buying or selling PBIGF?

Recent insider trading data for PBIGF is being updated.

What is PBIGF insider trading activity?

Check back for the latest PBIGF insider trading activity.

Why do insiders buy PBIGF stock?

Insiders (executives, directors, major shareholders) may buy PBIGF stock because they believe it's undervalued or expect positive developments. Insider buying is often seen as a bullish signal since they have deep knowledge of the company.

Why do insiders sell PBIGF stock?

Insiders may sell for various reasons including diversification, personal financial needs, or as part of planned 10b5-1 trading plans. Insider selling doesn't always indicate bearish sentiment - context matters.

What is the net insider activity for PBIGF?

Net insider activity data for PBIGF will be available when recent transactions are reported.

How do I track PBIGF insider trades?

PBIGF insider trades are disclosed through SEC Form 4 filings, which must be submitted within 2 business days of the transaction. This page automatically tracks and displays the latest Form 4 filings for Paradigm Biopharmaceuticals Limited.

What is a 10b5-1 trading plan for PBIGF?

A 10b5-1 trading plan allows PBIGF insiders to set up predetermined trading schedules when they don't have material non-public information. This protects executives from insider trading accusations while allowing them to diversify holdings.

Is PBIGF insider buying a good sign?

PBIGF insider buying can be a positive signal since executives know the company intimately. However, context matters - consider the size of purchases relative to their holdings, the number of insiders buying, and whether it's open market purchases versus options exercises.